Stockhub

THELMA Therapeutics Co., Ltd.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

22 September 2022

  • curprev 09:4809:48, 22 September 2022 95.149.241.133 talk 666 bytes +666 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == THELMA Therapeutics Co., Ltd. operates as a biopharmaceutical company in South Korea and internationally. The company develops TLM-01, a non-alcoholic steatohepatitis drug; TLM-02, an antiviral agent for COVID-19; TLM-03/TLM-04, an anticancer drug for solid and blood cancer; and TLM-05, a liver cancer drug. It also offers radioembolization and brachytherapy devices for the cancer treatments. The company was formerly known a..."
Retrieved from "https://stockhub.co/research/THELMA_Therapeutics_Co.,_Ltd."